All Articles
Diagnostic Strategy and Drug Strategy - Alignment and Integration

Diagnostic Strategy and Drug Strategy - Alignment and Integration

6 September, 2015

In Part 2 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses integrating and aligning the diagnostic strategy with the drug strategy.|In Part 2 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses integrating and aligning the diagnostic strategy with the drug strategy.|In Part 2 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses integrating and aligning the diagnostic strategy with the drug strategy.|In Part 2 of the series, ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses integrating and aligning the diagnostic strategy with the drug strategy.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny